1-2 of 2
Keywords: Fluorescent in situ hybridization
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SRY-Positive 46,XX Male with Cryptorchidism as the Only Presenting Clinical Feature

Available to Purchase
Subject Area:
Further Areas
Marta Moreno-García, Jaime Sánchez del Pozo, Pilar Gutierrez-Díez, Belén Gil-Fournier, Emilia Barreiro Miranda
Journal: Urologia Internationalis
Urol Int (2003) 71 (2): 219–221.
https://doi.org/10.1159/000071852
Published Online: 07 August 2003
... phenotype and female karyotype (46,XX) with cryptorchidism as the only presenting clinical abnormality. Fluorescent in situ hybridization analysis, using Y- and X-specific (whole chromosome painting WCP Y WCP X) DNA and SRY probes, detected a small Y chromosome fragment, including the SRY gene, transferred...
View article titled, SRY-Positive 46,XX Male with Cryptorchidism as the Only Presenting Clinical Feature
Open the PDF for SRY-Positive 46,XX Male with Cryptorchidism as the Only Presenting Clinical Feature in another window
Journal Articles

Superficial Bladder Tumors in Patients under 40 Years of Age: Clinical, Prognostic and Cytogenetic Aspects

Available to Purchase
Subject Area:
Further Areas
F. Iori, C. De Dominicis, M. Liberti, D. Frioni, M. Vahedi, C. Leonardo, C. de Nunzio, C. Laurenti
Journal: Urologia Internationalis
Urol Int (2001) 67 (3): 224–227.
https://doi.org/10.1159/000050992
Published Online: 05 October 2001
... fluorescent in situ hybridization with probes for the centromere of chromosomes 7 and 17 showed a high incidence of aneusomy with regard to these chromosomes and a genetic difference between superficial tumors in the young and in adults. Using probes from chromosomes already described in bladder...
View article titled, Superficial Bladder Tumors in Patients under 40 Years of Age: Clinical, Prognostic and Cytogenetic Aspects
Open the PDF for Superficial Bladder Tumors in Patients under 40 Years of Age: Clinical, Prognostic and Cytogenetic Aspects in another window